Detalhe da pesquisa
1.
End points in clinical trials in diffuse large B-cell lymphoma: time for more dialogue?
Future Oncol
; : 1-15, 2024 Jun 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38889345
2.
Perspectives in Immunotherapy: meeting report from Immunotherapy Bridge (Naples, November 30th-December 1st, 2022).
J Transl Med
; 21(1): 488, 2023 07 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37475035
3.
Perspectives in Immunotherapy: meeting report from the Immunotherapy Bridge, December 1st-2nd, 2021.
J Transl Med
; 20(1): 257, 2022 06 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35672823
4.
A vaccine directed to B cells and produced by cell-free protein synthesis generates potent antilymphoma immunity.
Proc Natl Acad Sci U S A
; 109(36): 14526-31, 2012 Sep 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-22875703
5.
In situ vaccination against mycosis fungoides by intratumoral injection of a TLR9 agonist combined with radiation: a phase 1/2 study.
Blood
; 119(2): 355-63, 2012 Jan 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-22045986
6.
T-cell States, Repertoire, and Function in Classical Hodgkin Lymphoma Revealed through Single-Cell Analyses.
Cancer Immunol Res
; 12(3): 296-307, 2024 03 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38240659
7.
Phase I Study of GS-3583, a FLT3 Agonist Fc Fusion Protein, in Patients with Advanced Solid Tumors.
Clin Cancer Res
; 2024 Jan 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-38295150
8.
Society for Immunotherapy of Cancer (SITC) recommendations on intratumoral immunotherapy clinical trials (IICT): from premalignant to metastatic disease.
J Immunother Cancer
; 12(4)2024 Apr 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38641350
9.
Immunotherapy-resistant acute lymphoblastic leukemia cells exhibit reduced CD19 and CD22 expression and BTK pathway dependency.
J Clin Invest
; 134(8)2024 Feb 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38376944
10.
A CpG-loaded tumor cell vaccine induces antitumor CD4+ T cells that are effective in adoptive therapy for large and established tumors.
Blood
; 117(1): 118-27, 2011 Jan 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-20876455
11.
Signaling pathways in lymphoma: pathogenesis and therapeutic targets.
Future Oncol
; 9(10): 1549-71, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24106904
12.
Brentuximab vedotin as a bridge to combination chemotherapy in gray zone lymphoma with severe liver impairment: a case report.
Front Oncol
; 13: 1254256, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38313213
13.
Pattern recognition receptor agonists in pathogen vaccines mediate antitumor T-cell cross-priming.
J Immunother Cancer
; 11(7)2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37487664
14.
Pembrolizumab for patients with non-Hodgkin lymphoma: phase 1b KEYNOTE-013 study.
Leuk Lymphoma
; 64(1): 130-139, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36398795
15.
Dendritic cells and lymphoma cells: come together right now.
Blood
; 125(1): 5-7, 2015 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25554743
16.
Cancer vaccines: the next immunotherapy frontier.
Nat Cancer
; 3(8): 911-926, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35999309
17.
Expanding cross-presenting dendritic cells enhances oncolytic virotherapy and is critical for long-term anti-tumor immunity.
Nat Commun
; 13(1): 7149, 2022 11 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-36418317
18.
Immunotransplantation preferentially expands T-effector cells over T-regulatory cells and cures large lymphoma tumors.
Blood
; 113(1): 85-94, 2009 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18812472
19.
Idiotype vaccine strategies for treatment of follicular lymphoma.
Future Oncol
; 7(1): 111-22, 2011 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-21174542
20.
Biomarkers of response to ibrutinib plus nivolumab in relapsed diffuse large B-cell lymphoma, follicular lymphoma, or Richter's transformation.
Transl Oncol
; 14(1): 100977, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33395752